Explore the latest advances in alopecia areata treatment, including FDA-approved JAK inhibitors and promising topical ...

Long term data were announced from a phase 3 trial evaluating baricitinib in adolescents aged 12 to less than 18 years with severe alopecia areata.

Male pattern baldness (androgenetic alopecia) affects up to half of men by middle age. Early detection and treatment can ...